Successful Xenotransplantation Surgery in China

Three Extra Days Secured with a Pig Liver

A Breakthrough Solution to the Shortage of Human Organ Donations

The transplantation of animal organs into humans, known as xenotransplantation, is garnering attention as a new option to save patients' lives. This approach involves using animal organs to extend the critical golden time before a patient receives a human organ transplant.


The international academic journal Nature reported on March 6 (local time) a successful case of xenotransplantation at Xijing Hospital of the Air Force Medical University in Xi'an, China. Xenotransplantation refers to a treatment method in which animal organs, tissues, or cells—such as those from pigs—are transplanted into humans, and it was developed to address the shortage of human organ donations.


On the 3rd of last month (local time), medical staff at Xijing Hospital of the Air Force Medical University in Xi'an, Shanxi Province, northwest China, checked the condition of a patient who had undergone surgery to connect an extracorporeal circulation device made from a pig liver. Photo by Xinhua News Agency Yonhap News

On the 3rd of last month (local time), medical staff at Xijing Hospital of the Air Force Medical University in Xi'an, Shanxi Province, northwest China, checked the condition of a patient who had undergone surgery to connect an extracorporeal circulation device made from a pig liver. Photo by Xinhua News Agency Yonhap News

View original image

The medical team led by Dr. Wang Lin decided to transplant a genetically modified pig liver into a 56-year-old man suffering from chronic hepatitis B. The patient required a liver transplant due to liver failure, but at the time, there were no donated livers available at the hospital. After Dr. Wang Lin's surgery, the man was able to survive for three days thanks to the pig liver, after which he successfully received a human organ transplant.


The device created by Dr. Wang Lin's team is an extracorporeal circulation device using a pig liver. Direct transplantation of animal organs into humans typically triggers a severe immune rejection response, making it dangerous. Instead, the medical team used CRISPR gene-editing technology to remove three genes from the pig liver and inserted three human genes responsible for producing human proteins. The device made from the pig liver was then connected to the patient's leg vein.


As the patient's blood circulated through the external pig liver, toxic substances could be filtered out. There was no immune rejection response, and the patient's internal liver function improved. The patient, who gained a valuable three-day golden time, subsequently underwent surgery with a donated human organ.


This type of treatment had previously been attempted in the United States last February. At that time, American medical staff connected extracorporeal circulation devices to the blood vessels of four brain-dead patients, successfully achieving extracorporeal circulation in three of them. However, this is the first reported case of this procedure being successfully performed on a living patient.



This surgery is being highlighted as a significant breakthrough that could save the lives of patients who cannot receive donated organs. According to the World Health Organization (WHO), every ten minutes, a patient on the organ transplant waiting list dies because they do not receive an organ in time. When considering those who have not even made it onto the waiting list, the actual number of deaths is estimated to be much higher.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing